IP Library Granted Patent US 10,752,944
Granted Patent B2
US 10,752,944 · App. 14/342,725 · Granted Aug 25, 2020

Circularized templates for sequencing

Inventors: Steven T. Brentano (Santee, CA); Dmitry Lyakhov (San Diego, CA); Matthew C. Friedenberg (San Diego, CA); Anne-Laure Shapiro (La Jolla, CA)
Assignee: GEN-PROBE INCORPORATED
C12Q1/6869C12Q1/6844C12Q1/6855
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,752,944
App. No.
14/342,725
Granted
Aug 25, 2020
Kind
B2
Abstract

The invention provides methods of forming a circular template for sequencing a target nucleic acid. The circular template is generated by amplification of a segment of the target nucleic acid with chimeric primers with complementary 5′ ends. The circular template has a single nick or gap providing a site for initiation of template-directed extension for sequence analysis. Sequencing of a single template generates reads of alternating segments of the same strand of the target nucleic spaced by primer segments. The different reads of the same strand of the target nucleic acid can be compiled to generate a consensus sequence. Because only one strand of the target nucleic acid is sequenced per reaction, the present method avoids errors introduced by unwittingly combining sequences of both strands of a heteroduplex PCR product. Because only one strand of the target nucleic acid is sequenced per reaction, the present method avoids errors introduced by unwittingly combining sequences of both strands of a heteroduplex PCR product.

Claims (28)

1. A method of forming a circular template for sequencing a target nucleic acid, comprising:

(a) contacting a target nucleic acid with a primer pair under PCR conditions, each of the primers having a 3′ segment and a 5′ segment, the 3′ segments of the primers being target-binding segments, the 5′ segments being mutually complementary in opposing orientations, a first of the primers having a 5′ phosphate group and the second of the primers lacking a 5′ phosphate and/or having a shorter 5′ segment than the first primer; thereby forming an amplified nucleic acid comprising a segment of the target nucleic acid flanked by the primers duplexed with their complementary segments;

(b) contacting the amplified nucleic acid with a nucleic acid polymerase having a 3′ to 5′ exonuclease activity and one or more nucleobase units in solution, wherein the polymerase with exonuclease activity digests at least parts of the amplified nucleic acid complementary to the 5′ segments of the primers, the digested nucleobase units of the parts complementary to the 5′ segments being of a type different than the one or more nucleobase units in solution, and the amplified nucleic acid circularizes via annealing of the 5′ segments; and

(c) contacting the circularized nucleic acid with a ligase which seals a nick between the 5′ phosphate group of the first primer and an adjacent 3′ hydroxyl group in a strand of the circularized nucleic acid leaving the circularized nucleic acid with a single nick or gap between the 5′ segment of the second primer and a 3′ hydroxyl of an adjacent nucleotide in a complementary strand thereby forming the circular template for sequencing the target nucleic acid.

2. A method of forming a circular template for sequencing a target nucleic acid, comprising:

(a) contacting a target nucleic acid with a primer pair under PCR conditions, each of the primers having a 3′ segment and a 5′ segment, the 3′ segments of the primers being target-binding segments, the 5′ segments being mutually complementary in opposing orientations, a first of the primers having a 5′ phosphate group and the second of the primers lacking a 5′ phosphate and/or having a shorter 5′ segment than the first primer; thereby forming an amplified nucleic acid comprising a segment of the target nucleic acid flanked by the primers duplexed with their complementary segments;

(b) contacting the amplified nucleic acid with a nucleic acid polymerase having a 3′ to 5′ exonuclease activity and one or more nucleobase units in solution, the nucleobase units in solution being of a type different than the nucleobase units complementary to the nucleobase units in the 5′ segments of the primers, wherein the polymerase with exonuclease activity digests at least parts of the amplified nucleic acid complementary to the 5′ segments of the primers, and the amplified nucleic acid circularizes via annealing of the 5′ segments; and

(c) contacting the circularized nucleic acid with a ligase which seals a nick between the 5′ phosphate group of the first primer and an adjacent 3′ hydroxyl group in a strand of the circularized nucleic acid leaving the circularized nucleic acid with a single nick or gap between the 5′ segment of the second primer and a 3′ hydroxyl of an adjacent nucleotide in a complementary strand thereby forming the circular template for sequencing the target nucleic acid.

3. The method of claim 1 , wherein each primer further comprises a cushion segment between the 5′ segment and the 3′ segment, the cushion segment including at least one nucleobase unit complementary to a type of the one or more nucleobase units in solution, whereby the exonuclease digestion terminates at or in the complements of the cushion segments in the amplified nucleic acid.

4. The method of claim 3 , wherein the cushion segment nucleobase unit(s) consist of a single type of canonical nucleobase unit, and the 5′ segment nucleobase units consist of the two canonical nucleobase types other than the single type of canonical nucleobase and its complement except that if one 5′ segment is longer than the other, the extra portion of the longer 5′ segment may contain the single type of canonical nucleobase unit.

5. The method of claim 3 , wherein the cushion segment nucleobase units consist of two types of canonical nucleobase units complementary to one another and the 5′ segments nucleobase units consist of the other two types of canonical nucleobase unit.

6. The method of claim 3 , wherein nucleobase units of the cushion region consist of A, or T/U, or A and T/U, and the nucleobase units of the 5′ regions consist of C and G.

7. The method of claim 3 , wherein the nucleobase units of the cushion region consist of C or G, or C and G, and the nucleobase units of the 5′ regions consist of A and T/U.

8. The method of claim 3 , wherein a 5′ segment or cushion segment of the first and/or second primer includes one or more noncanonical nucleobase units.

9. The method of claim 3 , wherein all nucleobase units in the primer are canonical nucleobase units.

10. The method of claim 1 , wherein the target nucleic acid is a genomic DNA molecule, or a cDNA molecule or an RNA molecule.

11. The method of claim 1 , wherein the nucleic acid polymerase is a T4 DNA polymerase.

12. The method of claim 1 , wherein the ligase is a T4 DNA ligase.

13. The method of claim 1 , wherein the ligase is a thermophilic DNA ligase and step (c) is performed at a temperature over 40 degrees.

14. The method of claim 1 , wherein the 5′ segment of the first primer is longer than the 5′ segment of the second primer resulting in a gap between the 5′ end of the second primer and a 3′ hydroxyl of an adjacent nucleotide in the amplified nucleic acid.

15. The method of claim 14 , wherein the 5′ segment of the first primer is longer than the 5′ segment of the second primer by four nucleobase units and the gap is four nucleobase units.

16. The method of claim 1 , wherein contacting steps (b) and (c) are performed at the same time.

17. The method of claim 1 , wherein the PCR conditions including at least ten thermocycles.

18. The method of claim 1 , wherein each of the primers has a 5′ segment of at least 5 nucleobase units.

19. The method of claim 1 , wherein each of the primers has a 3′ segment of at least 10 nucleobase units.

20. A method for sequencing a target nucleic acid comprising the steps of:

(a) contacting a double-stranded circularized template with a polymerase and nucleobase units, wherein the template comprises a target nucleic acid segment and a single nick or gap in one of its strands made by the method of claim 1 ; and

(b) conducting template directed-extension from a free 3′-hydroxyl of a nucleobase unit abutting the nick or gap directed by the circular template incorporating the nucleobase units into a nascent chain including multiple copies of the same strand of the target nucleic acid segment; and detecting the incorporation of nucleobase units in the nascent chain to determine the sequence of the strand of the target nucleic acid segment.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Apr 28, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC., ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO DIRECT RADIOGRAPHY CORP.; CYTYC CORPORATION, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO BIOLUCENT, LLC; CYTYC SURGICAL PRODUCTS, LLC, AS SUCCESSOR-BY-CONVERSION TO CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; GEN-PROBE INCORPORATED, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.
Reel/Frame 075566/0039 →
RELEASE OF SECURITY INTEREST RECORDED AT REEL/FRAME 054089/0804 Recorded Apr 28, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC., ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO FOCAL THERAPEUTICS, INC.; GEN-PROBE INCORPORATED; FAXITRON BIOPTICS, LLC; GEN-PROBE PRODESSE, INC.
Reel/Frame 075504/0575 →
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →
SECURITY INTEREST Recorded Oct 15, 2020
From: HOLOGIC, INC.; FAXITRON BIOPTICS, LLC; FOCAL THERAPEUTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 054089/0804 →
SECURITY AGREEMENT Recorded Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 18, 2014
From: BRENTANO, STEVEN T.; LYAKHOV, DMITRY; FRIEDENBERG, MATTHEW C.; SHAPIRO, ANNE-LAURE
To: GEN-PROBE INCORPORATED
Reel/Frame 033132/0985 →
Continuity (2)
Provisional Application 61531580 · Sep 6, 2011
Related Publication 20140378318A1 · Dec 25, 2014